TCT-642 The Comparative Effectiveness and Safety of Cangrelor vs. In- lab Glycoprotein IIb/IIIa Inhibitor (GPI) in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Subjects

Subjects :

*PRASUGREL
*PERCUTANEOUS coronary intervention
*CARDIOGENIC shock

Details

Language :

English

ISSN :

07351097

Volume :

72

Issue :

13

Database :

Academic Search Index

Journal :

Journal of the American College of Cardiology (JACC)

Publication Type :

Academic Journal

Accession number :

131883551

Full Text :

https://doi.org/10.1016/j.jacc.2018.08.1848